About o2h
o2h is a company based in Cambridge (United States) founded in 2005 by Sunil Rajen Shah. It operates as a B2B and SaaS. The company has 523 employees as of March 31, 2023. o2h offers products and services including Integrated Drug Discovery, Chemistry Services, Biology Services, and Chemistry in the Cloud. o2h operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
- Headquarter Cambridge, United States
- Employees 523 as on 31 Mar, 2023
- Founders Sunil Rajen Shah
-
Sectors
Chemicals & MaterialsHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name O2h Discovery Private Limited
- Jurisdiction Ahmedabad, Gujarat, India
-
Annual Revenue
$15.64 M (USD)12950102.9as on Mar 31, 2023
-
Net Profit
$2.18 M (USD)13055162.16as on Mar 31, 2023
-
EBITDA
$4.88 M (USD)13756613.2as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
523
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of o2h
o2h offers a comprehensive portfolio of products and services, including Integrated Drug Discovery, Chemistry Services, Biology Services, and Chemistry in the Cloud.
Service for advancing ideas from target validation to pre-clinical candidates.
Provides medicinal and synthetic chemistry for drug discovery projects.
Offers biophysical and cellular assays for research collaboration.
App for secure cloud-based drug discovery program management.
People of o2h
Unlock access to complete
Funding Insights of o2h
Detailed funding history for o2h
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by o2h
Investment portfolio details for o2h
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - o2h
Detailed financials for o2h
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
O2h Comparisons
Peer comparison for o2h
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of o2h
o2h operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services are provided to biopharma sector.
|
|
| Locked | Locked | Locked |
Cancer and CVMD drugs are developed using PDX models.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided for therapeutic development.
|
|
| Locked | Locked | Locked |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery and development research services are provided.
|
Detailed competitors of o2h
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on O2h
Complete news archive for o2h
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about o2h
o2h was founded in 2005.
o2h is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
As of Mar 31, 2023, the latest employee count at o2h is 523.
Annual revenue of o2h is $15.64M as on Mar 31, 2023.
o2h discovery is a contract research organization specializing in integrated drug discovery, including chemistry and biology services. It operates from research centers in Ahmedabad, India, and Cambridge, UK, delivering innovative solutions like fragment-based drug discovery and in-vitro ADME. The company collaborates with global pharma and biotech firms, focusing on efficient project management and sustainable practices to advance drug development from target validation to pre-clinical stages.
o2h's top competitors include Evotec, Crown Bioscience and NIH.
o2h offers Integrated Drug Discovery, Chemistry Services, Biology Services, and Chemistry in the Cloud.